Trial Profile
Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis?
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Pregabalin (Primary)
- Indications Dry eyes; Neuropathic pain
- Focus Therapeutic Use
- 03 Jan 2019 Status changed from active, no longer recruiting to completed.
- 15 May 2018 Planned End Date changed from 1 Jun 2018 to 1 Dec 2018.
- 15 May 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.